CRMD vs. EDD
CRMD (CorMedix Inc.) is a stock, while EDD (Morgan Stanley Emerging Markets Domestic Fund) is Emerging Markets Bonds fund managed by Morgan Stanley. Over the past 10 years, CRMD returned -0.74%/yr vs 5.82%/yr for EDD. At a 0.11 correlation, their price movements are largely independent.
Performance
CRMD vs. EDD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRMD achieves a -27.77% return, which is significantly lower than EDD's 13.61% return. Over the past 10 years, CRMD has underperformed EDD with an annualized return of -0.74%, while EDD has yielded a comparatively higher 5.82% annualized return.
CRMD
- 1D
- -3.11%
- 1M
- -6.25%
- 6M
- 10.09%
- YTD
- -27.77%
- 1Y
- -25.13%
- 3Y*
- 29.03%
- 5Y*
- 3.74%
- 10Y*
- -0.74%
EDD
- 1D
- -0.52%
- 1M
- 7.32%
- 6M
- 8.80%
- YTD
- 13.61%
- 1Y
- 25.08%
- 3Y*
- 18.30%
- 5Y*
- 8.49%
- 10Y*
- 5.82%
CRMD vs. EDD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRMD CorMedix Inc. | -27.77% | 43.58% | 115.43% | -10.90% | -7.25% | -38.76% | 2.06% | 12.87% | 158.00% | -67.32% |
EDD Morgan Stanley Emerging Markets Domestic Fund | 13.61% | 32.46% | 8.64% | 14.09% | -14.15% | -7.03% | -2.84% | 25.45% | -14.09% | 16.34% |
Correlation
The correlation between CRMD and EDD is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since May 13, 2010 | 0.11 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRMD vs. EDD — Risk / Return Rank
CRMD
EDD
CRMD vs. EDD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CorMedix Inc. (CRMD) and Morgan Stanley Emerging Markets Domestic Fund (EDD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRMD | EDD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.97 | ||
| Sortino ratioReturn per unit of downside risk | -2.37 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 1.27 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | -0.49 | 1.44 | -1.93 |
| Martin ratioReturn relative to average drawdown | -0.75 | 4.62 | -5.37 |
Loading charts...
Drawdowns
CRMD vs. EDD - Drawdown Comparison
The maximum CRMD drawdown since its inception was -98.28%, which is greater than EDD's maximum drawdown of -59.38%. Use the drawdown chart below to compare losses from any high point for CRMD and EDD.
Loading charts...
Drawdown Indicators
| CRMD | EDD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.28% | -59.38% | -38.90% |
Max Drawdown (1Y)Largest decline over 1 year | -57.86% | -17.67% | -40.19% |
Max Drawdown (3Y)Largest decline over 3 years | -62.26% | -17.67% | -44.59% |
Max Drawdown (5Y)Largest decline over 5 years | -62.63% | -32.04% | -30.59% |
Max Drawdown (10Y)Largest decline over 10 years | -94.77% | -42.70% | -52.07% |
Current DrawdownCurrent decline from peak | -82.98% | -2.04% | -80.94% |
Average DrawdownAverage peak-to-trough decline | -77.57% | -24.13% | -53.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.68% | 5.50% | +32.18% |
Volatility
CRMD vs. EDD - Volatility Comparison
CorMedix Inc. (CRMD) has a higher volatility of 14.53% compared to Morgan Stanley Emerging Markets Domestic Fund (EDD) at 5.29%. This indicates that CRMD's price experiences larger fluctuations and is considered to be riskier than EDD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRMD | EDD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.53% | 5.29% | +9.24% |
Volatility (6M)Calculated over the trailing 6-month period | 51.46% | 13.43% | +38.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 63.35% | 16.67% | +46.68% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.14% | 15.47% | +61.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 91.65% | 17.64% | +74.01% |
Dividends
CRMD vs. EDD - Dividend Comparison
CRMD has not paid dividends to shareholders, while EDD's dividend yield for the trailing twelve months is around 10.94%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRMD CorMedix Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EDD Morgan Stanley Emerging Markets Domestic Fund | 10.94% | 9.76% | 11.45% | 7.30% | 6.82% | 6.93% | 6.92% | 8.15% | 9.90% | 8.18% | 10.32% | 12.65% |
Frequently Asked Questions
CRMD and EDD have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRMD has higher volatility (14.53%) compared to EDD (5.29%). In terms of maximum drawdown, CRMD dropped -98.28% vs EDD's -59.38%.
EDD currently has the higher Sharpe Ratio (1.53 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRMD and EDD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer